April 25 (Reuters) - The U.S. Food and Drug
Administration on Thursday sent a warning letter to Cardinal
Health ( CAH ) after an inspection of its facility in Illinois
showed that the company was marketing unapproved devices.
(Reporting by Pratik Jain in Bengaluru)